Skip to content

Welcome to Discover Pharma! Today is : November 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Like the ten leaping Lords, PHARMASEAL takes a leap towards smarter growth in 2026

    With the lords a-leaping, the industry is set to spring [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Amorphical reports positive long-term Phase 2 results for Crohn’s disease therapy

    Amorphical has announced positive final long-term results from its Phase [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Therapeutic Areas

    Study highlights laser device that could delay knee replacement surgery

    A newly published study has introduced a minimally invasive laser [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    MediciNova completes patient enrollment in Phase 2 neuropathy prevention study

    MediciNova has completed patient enrollment in a Phase 2 clinical [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    NICE recommends amivantamab and lazertinib as first-line option for EGFR-mutated lung cancer

      The National Institute for Health and Care Excellence has [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Nine ladies dancing: uMotif – patient-centric trials and AI take centre stage in 2026

    As part of Discover Pharma’s 12 days of Christmas series, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Manufacturing & Supply Chain,Opinion & Events

    Seven lords a-leaping: Gifthealth CEO on why DTP must blend high tech with high touch in 2026

    For Seven lords a-leaping, Discover Pharma turns to Chip Parkinson, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Six geese a-laying: CluePoints’ AI predictions for 2026

    As our Christmas countdown continues, we move from reflections on [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    PHARMASEAL: five gold rings that shaped clinical operations in 2025

    Like the five gold rings in the Christmas carol, 2025 [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    uMotif: patient-centricity took flight again in 2025 like four calling birds

    In 2025, patient-centricity, just like the four calling birds soared [...]

    May 5, 2026
Previous414243Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Remepy raises $36M to advance Parkinson’s drug into Phase 3
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing
    Categories: Manufacturing & Supply Chain
  • Tufts analysis finds AI clinical monitoring could cut trial costs and development time
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top